Roche extends China deal streak with $1B pact for RNAi obesity drug
BioPharma DiveJonathan GardnerOctober 13, 2026
An alliance with Rona Therapeutics adds to a particularly active stretch for Roche and makes the company the latest to bet on medicines that can lower levels of visceral fat.